Cardiovascular disease and risk factors in PCOS women of postmenopausal age: A 21-year controlled follow-up study

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 12, 2011, Pages 3794-3803

  Schmidt, Johanna ^a   Landin Wilhelmsen, Kerstin ^a   Brännström, Mats ^a   Dahlgren, Eva ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MORBIDITY; MORTALITY; NEOPLASM; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; STROKE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INSULIN; MIDDLE AGED; POLYCYSTIC OVARY SYNDROME; POSTMENOPAUSE; PREVALENCE; REGISTRIES; RISK FACTORS; TRIGLYCERIDES;

EID: 83155165470     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1677     Document Type: Article

References (40)

1. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19-25
2. Legro RS, Kunselman AR, Dodson WC, Dunaif A 1999 Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84:165-169 (Pubitemid 29036695)
3. Dunaif A, Segal KR, Futterweit W, Dobrjansky A 1989 Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38:1165-1174 (Pubitemid 19250404)
4. Elting MW, Korsen TJ, Bezemer PD, Schoemaker J 2001 Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population. Hum Reprod 16:556-560 (Pubitemid 32218809)
5. Holte J, Gennarelli G, Berne C, Bergh T, Lithell H 1996 Elevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: a sign of a pre-hypertensive state? Hum Reprod 11:23-28 (Pubitemid 26047667)
6. Diamanti-Kandarakis E, Papavassiliou AG, Kandarakis SA, Chrousos GP 2007 Pathophysiology and types of dyslipidemia in PCOS. Trends Endocrinol Metab 18:280-285 (Pubitemid 47332216)
7. Talbott EO, Guzick DS, Sutton-Tyrrell K, McHugh-Pemu KP, Zborowski JV, Remsberg KE, Kuller LH 2000 Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol 20:2414-2421
8. Valkenburg O, Steegers-Theunissen RP, Smedts HP, Dallinga-Thie GM, Fauser BC, Westerveld EH, Laven JS 2008 A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study. J Clin Endocrinol Metab 93:470-476 (Pubitemid 351240818)
9. Dahlgren E, Johansson S, Lindstedt G, Knutsson F, Odén A, Janson PO, Mattson LA, Crona N, Lundberg PA 1992 Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertil Steril 57:505-513
10. Dahlgren E, Janson PO, Johansson S, Lapidus L, Lindstedt G, Tengborn L 1994 Hemostatic and metabolic variables in women with polycystic ovary syndrome. Fertil Steril 61:455-460 (Pubitemid 24083145)
11. Glueck CJ, Papanna R, Wang P, Goldenberg N, Sieve-Smith L 2003 Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. Metabolism 52:908-915 (Pubitemid 36957780)
12. Expert panel on detection eaToHBCiA 2001 Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285:2486-2497.
13. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen MR, Groop L 2001 Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683-689 (Pubitemid 32893993)
14. Trevisan M, Liu J, Bahsas FB, Menotti A 1998 Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group. Am J Epidemiol 148:958-966
15. Dahlgren E, Janson PO, Johansson S, Lapidus L, Odén A 1992 Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women. Acta Obstet Gynecol Scand 71:599-604 (Pubitemid 23050339)
16. Pierpoint T, McKeigue PM, Isaacs AJ, Wild SH, Jacobs HS 1998 Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol 51:581-586 (Pubitemid 28376967)
17. Wild S, Pierpoint T, McKeigue P, Jacobs H 2000 Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clin Endocrinol (Oxf) 52:595-600 (Pubitemid 30337085)
18. Schmidt J, Brännström M, Landin-Wilhelmsen K, Dahlgren E 2011 Reproductive hormone levels and anthropometry in postmenopausal women with polycystic ovary syndrome (PCOS): a 21-year follow-up study of women diagnosed with PCOS around 50 years ago and their age-matched controls. J Clin Endocrinol Metab 96:2178-2185
19. Wilhelmsen L, Johansson S, Rosengren A, Wallin I, Dotevall A, Lappas G 1997 Risk factors for cardiovascular disease during the period 1985-1995 in Goteborg, Sweden. The GOT-MONICA Project. J Intern Med 242:199-211 (Pubitemid 27400432)
20. Wilhelmsen L, Tibblin G, Aurell M, Bjure J, Ekström-Jodal B, Grimby G 1976 Physical activity, physical fitness and risk of myocardial infarction. Adv Cardiol 18:217-230
21. Clauss A 1957 [Rapid physiological coagulation method in determination of fibrinogen]. Acta Haematol 17:237-246 (German)
22. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L 2004 Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364:937-952 (Pubitemid 39208455)
23. Eriksson M, Holmgren L, Janlert U, Jansson JH, Lundblad D, Stegmayr B, Söderberg S, Eliasson M 2011 Large improvements in major cardiovascular risk factors in the population of northern Sweden: the MONICA study 1986-2009. J Intern Med 269:219-231
24. Rosengren A, Tibblin G, Wilhelmsen L 1991 Self-perceived psychological stress and incidence of coronary artery disease in middle-aged men. Am J Cardiol 68:1171-1175
25. Conway GS, Agrawal R, Betteridge DJ, Jacobs HS 1992 Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol (Oxf) 37:119-125
26. Mineo C, Deguchi H, Griffin JH, Shaul PW 2006 Endothelial and antithrombotic actions of HDL. Circ Res 98:1352-1364 (Pubitemid 43948059)
27. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E 2001 High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358:2026-2033 (Pubitemid 34084825)
28. Kaptoge S, White IR, Thompson SG, Wood AM, Lewington S, Lowe GD, Danesh J 2007 Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies: the fibrinogen studies collaboration. Am J Epidemiol 166:867-879 (Pubitemid 47511690)
29. Dotevall A, Johansson S, Wilhelmsen L 1994 Association between fibrinogen and other risk factors for cardiovascular disease in men and women. Results from the Goteborg MONICA survey 1985. Ann Epidemiol 4:369-374 (Pubitemid 24300240)
30. Mannerås-Holm L, Baghaei F, Holm G, Janson PO, Ohlsson C, Lönn M, Stener-Victorin E 2011 Coagulation and fibrinolytic disturbances in women with polycystic ovary syndrome. J Clin Endocrinol Metab 96:1068-1076
31. Sills ES, Drews CD, Perloe M, Tucker MJ, Kaplan CR, Palermo GD 2003 Absence of profound hyperinsulinism in polycystic ovary syndrome is associated with subtle elevations in the plasminogen activator inhibitor system. Gynecol Endocrinol 17:231-237 (Pubitemid 36760724)
32. Landin K, Stigendal L, Eriksson E, Krotkiewski M, Risberg B, Tengborn L, Smith U 1990 Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism 39:1044-1048 (Pubitemid 20351262)
33. Puurunen J, Piltonen T, Morin-Papunen L, Perheentupa A, Järvelä I, Ruokonen A, Tapanainen JS 2011 Unfavorable Hormonal, Metabolic, and Inflammatory Alterations Persist after Menopause in Women with PCOS. J Clin Endocrinol Metab 96:1827-1834
34. Harmsen P, Wilhelmsen L, Jacobsson A 2009 Stroke incidence and mortality rates 1987 to 2006 related to secular trends of cardiovascular risk factors in Gothenburg, Sweden. Stroke 40:2691-2697
35. de Groot PC, Dekkers OM, Romijn JA, Dieben SW, Helmerhorst FM 2011 PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Hum Reprod Update 17:495-500
36. Shaw LJ, Bairey Merz CN, Azziz R, Stanczyk FZ, Sopko G, Braunstein GD, Kelsey SF, Kip KE, Cooper-Dehoff RM, Johnson BD, Vaccarino V, Reis SE, Bittner V, Hodgson TK, Rogers W, Pepine CJ 2008 Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health-National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab 93:1276-1284 (Pubitemid 351519721)
37. Mulders AG, Laven JS, Eijkemans MJ, de Jong FH, Themmen AP, Fauser BC 2004 Changes in anti-Mullerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility. Hum Reprod 19:2036-2042 (Pubitemid 39236470)
38. Flynn RW, Macdonald TM, Jung RT, Morris AD, Leese GP 2006 Mortality and vascular outcomes in patients treated for thyroid dysfunction. J Clin Endocrinol Metab 91:2159-2164 (Pubitemid 43854999)
39. Pillay OC, Te Fong LF, Crow JC, Benjamin E, Mould T, Atiomo W, Menon PA, Leonard AJ, Hardiman P 2006 The association between polycystic ovaries and endometrial cancer. Hum Reprod 21:924-929
40. Wild S, Pierpoint T, Jacobs H, McKeigue P 2000 Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study. Hum Fertil (Camb) 3:101-105